stability and quality of the prepared dosage form is still missing in most important pharmacopeias [ 10 ] . However, during the past decades multiple analytical methods have been developed to quantify DD in dosage forms, plasma and animal tissues. These methods include spectrophotometric determination [ 11 ] and high performance liquid chromatographic (UV and/or MS detector) methods [ 12 , 13 ] . In this study we succeeded in developing a novel isocratic reversed phase HPLC method using a UV detector to quantify a DD and Antipyrine combination in an injectable solution. To our knowledge there is no available method for analysis of this combination in liquid injectable dosage form. Very few analytical methods are available in the literature for analysis of diminazine [ 13 ] and antipyrine separately [ 14 -18 ] . Only one method is available in the literature for quantification of this combination in the form of a powder for injection [ 10 ] . The advantage of our method is that it is a simple method which can be used for routine and quality control analysis of a ready injectable solution. Moreover, the method is a stability indicating and can be used for purity and degradation evaluation of the formulation.A single isocratic run is used for the assay of both active ingredients in a relatively short time. In addition, the method has been successfully used for analysis of drug-excipient compatibility in
Introduction

▼
Diminazene diaceturate (DD) is a [4,4'-(diazoamino) dibenzaamidine]; DD is a diamidine derivative and is mainly used in the veterinary fi eld as a trypanocide and babesiacide in aff ected areas of the world [ 1 , 2 ] . It is still in common use for the treatment of babesiosis in cattle, cats, camel, goats, dogs, sheet, and swine [ 3 ] . It is also of useful in the treatment of ileriousis in combination with other antibiotics ( • ▶ Fig. 1a ). DD practically insoluble in water (6.67 mg/l) at room temperature, slightly soluble in alcohol and very slightly soluble in ether or chloroform [ 4 ] . Antipyrine was the fi rst pyrazolin-5-one derivative used as an analgesic, antipyretic and antiinfl ammatory drug ( • ▶ Fig. 1b ). It is a water soluble powder with slightly bitter taste [ 4 , 5 ] . Besides having antipyretic and analgesic activity [ 6 ] , antipyrine is also mixed with DD at a suitable concentrations as a stabilizer in most formulations, since DD is unstable in water on its own. Aqueous solutions of these preparations may remain stable for 10-15 days at room temperature [ 7 ] . A DD and Antipyrine combination is commercially available in the market as powder for injection and ready for use injectable solution [ 8 , 9 ] . Despite the importance and the widespread use of this combination, a suitable pharmaceutical quality control method for the evaluation of the ▼ Diminazene aceturate and Antipyrine combination therapy is widely used in veterinary medicine. A simple reverse HPLC method for the analysis of samples of a ready injectable formulation containing a mixture of active ingredients and inactive excipients has been developed. The HPLC analysis was carried out using a reversed phase (RP)-C18 (250 mm × 4.0 mm, 5 μm) column. The isocratic mobile phase consisted of a mixture of acetonitrile, methanol, phosphate buff er and hexane sulfonate; the fl ow rate was 0.6 mL/min and ultraviolet detection was at 291 nm. This method was validated in accordance with FDA and ICH guidelines and showed good linearity, accuracy, precision, selectivity and the system suitability results were within the acceptance criteria. A stability-indicating study was also carried out and indicated that this method could be used for purity and degradation evaluation of these formulations.
injectable formulations and subsequently an in house stability indicating study. Our main objective in this study was to establish a validated and stability indicating HPLC assay method for the determination of DD and Antipyrine in an injectable solution, formulated in the research laboratory at Advanced Veterinary Company-Ramallah, in accordance with the requirements of FDA and ICH guidelines [ 19 ] .
Experimental
▼
Chemicals and reagents
DD and Antipyrine active ingredients were purchased from A. B. Enterprises LTD, India and Zenita Life Science LTD, India respectively. USP reference standards were used to validate the method. The injection dosage form DD aceturate 70 mg per mL and Antipyrine (Phenazone) 375 mg per mL was formulated in house at our research laboratory. The methanol and acetonitrile used were of HPLC grade. The water for HPLC was obtained by double distillation. Other reagents such as Phosphate buff er, Phosphoric acid, Hexanesulfonic acid sodium salt, hydrochloric acid, sodium hydroxide, and hydrogen peroxide were purchased from Merck, Sigma Aldrech and J. T. Baker reliable commercial sources and were used as such.
Instrumentation
A Dionex-Ultimate 3000 HPLC system equipped with LPG-3400 SD pump, WPS-3000SL autosampler, TCC-3000 column oven, and DAD-3000 UV-VIS with diode array detector. Chromeleon Data system Software (Version 6.80 DU10A Build 2826 (171948)) was used for data acquisition and mathematical calculations. The HPLC grade water was prepared by Aquatron equipment model A4000D. The chromatographic conditions are outlined in • ▶ Table 1 .
Preparation of working solutions
DD (70 mg) and Antipyrine (375 mg) were weighed accurately into a 100 mL volumetric fl ask and dissolved in distilled water then 5 mL of this solution was diluted to 25 mL using the mobile phase (standard stock solution). The samples were prepared by diluting (1:10) of the injection formulation with distilled water and then 5 mL was diluted to 25 mL using the mobile phase to give solutions with concentrations equivalent to the standard stock solution.
Method validation
The method was validated for parameters like specifi city, linearity, range, accuracy, precision, LOD/LOQ and Ruggedness/Robustness. To evaluate the linearity and range of the method 5 diff erent test concentrations were prepared (based upon the original formulation): 60 %, 80 %, 100 %, 120 % and 140 %. 10 separate injections were analyzed under the same conditions. The accuracy and precision were established on 3 concentrations around the test concentration (80 %, 100 % and 120 %), 3 replicates of each concentration. The percentage recovery and % RSD were calculated for each of the replicate samples. The detection limit or LOD may be expressed as a concentration that gives a signal to noise ratio of approximately 3:1. While the Quantifi cation limit or LOQ in sample can be determined with acceptable precision and accuracy with a signal to noise ratio of approximately 10:1. The ruggedness/robustness of the method was determined by performing the same trial using diff erent mobile pH, detection wavelength, fl ow rate, elapsed assay time and analyst. The applied ruggedness parameters are illustrated in • ▶ Table 2 .
Forced degradation study
Forced degradation studies were performed to evaluate the stability indicating properties and specifi city of the method. Intentional degradation was carried out by exposing the formulation to 5 stress conditions, the condition mentioned in • ▶ Table 3 the general conditions which are generally followed in the stress study protocol. Stressed samples were analyzed periodically and the presence of related peaks and peak purity for the active ingredients was checked.
Result and Discussion
▼
Linearity and range
The linearity of the method was observed in the expected concentration range (60-140 %) for both DD and Antipyrine demonstrating its suitability for analysis as shown. The goodness-of-fi t (R 2 ) was found to be 0.9998 and 0.9999 indicating a linear relationship between the concentration of analyte and area under the peak.
Accuracy and precision
The results of accuracy studies done on both sample and reference standard showed that the method is accurate within the desired range. The RSD was calculated for each recovery solution of both active ingredients DD and Antipyrine, all the results are within limits. Acceptable precision of ± 1.13 % and ± 0.59 % were obtained for DD and Antipyrine respectively, accuracy was > 97 % ( • ▶ Table 4 , 5 ).
Stability indicating study
Stress testing of the drug injection DD and Antipyrine combination was done to identify the likely degradation products, the stability of the molecule and also validate specifi city of the analytical procedures. The stability indicating study was performed under various stress conditions mentioned in section 2. conditions (70 °C) when he original drug was exposed for 4 days. There was no evidence of degradation of the formulation stress with hydrogen peroxide or UV light.
Peak specifi city
There was no evidence of interference between the chromatographic peaks for DD and Antipyrine and the excipients, impurities and degradants products under the various stress conditions ( • ▶ Fig. 2a, b ) . The purity of all the peaks was tested using photodiode array (PDA) and the results showed that none of the tested peaks had a purity of less than 99 %.
Ruggedness & robustness
The ruggedness and robustness of the method were examined using some minor modifi cations listed in • ▶ Table 2 . The result indicated that minor modifi cations to the experimental parameters did not aff ect the assay and its ability to accurately and precisely detect/quantify the active ingredients.
System suitability
System suitability parameters are used to verify that the system is adequate for the analysis to be performed. The UV spectrum of DD and Antipyrine are shown in • ▶ Fig. 3 . Our method shows that all the values for the system suitability parameters are within acceptable limits, The column effi ciency was about 4055 and 10512 theoretical plates for DD and Antipyrine respectively. The tailing factors are about 2.0 and 1.6 for DD and Antipyrine respectively. The resolution values for DD and Antipyrine are 4.3 and 4.7 respectively.
Limit of detection and limit of quantifi cation:
The detection limit or LOD is the lowest amount of analyte in a sample that can be detected. While the Quantifi cation limit (LOQ) is the lowest amount of analyte in a sample that can be determined with acceptable precision and accuracy. Our method showed an LOD of 0.03 & 0.18 mg/L for DD and Antipyrine respectively. The LOQ was 0.11 &0.6 mg/L for DD and Antipyrine respectively.
Conclusion
▼
A simple and effi cient HPLC assay method utilizing UV detection has been developed for the analysis of a ready injectable solution of DD and Antipyrine combination. The method was novel, robust and economical and can be used for rapid assay of the 2 ingredients simultaneously. The developed method was vali- Table 6 The results of stability indicating studies.
Stress type Detectable change
Acid hydrolysis
No change Base hydrolysis
Degradant A.
Oxidative/solution
No change Thermal Degradant B.
Photo-degradation
No change.
Oxidative/solution
No change dated according to both FDA and ICH guidelines; it showed excellent accuracy, precision, linearity, selectivity and system suitability. The method is a stability-indicating and the results indicated that this method was suitable for evaluation of both purity and degradation.
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